−160 KRW
−1.75 B KRW
294.12 M KRW
15.78 M
About CHA VACCINE RESEARCH INSTITUTE
Sector
Industry
CEO
Jeong-Seon Yeom
Website
Headquarters
Seongnam-si
Founded
2000
ISIN
KR7261780001
FIGI
BBG0122YKZY0
CHA Vaccine Research Institute Co., Ltd. operates as a research-oriented biotechnology company. The firm involves in research and development of vaccine products targeting infectious disease as well as chronic disease. It specializes in proprietary vaccine adjuvant L-pampo and recombinant antigen development platform. The company was founded by Hong Mo Moon on June 13, 2000 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 261780 is 3,240 KRW — it has decreased by −0.61% in the past 24 hours. Watch CHA VACCINE RESEARCH INSTITUTE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CHA VACCINE RESEARCH INSTITUTE stocks are traded under the ticker 261780.
261780 stock has risen by 1.09% compared to the previous week, the month change is a −12.31% fall, over the last year CHA VACCINE RESEARCH INSTITUTE has showed a −40.55% decrease.
261780 reached its all-time high on Oct 22, 2021 with the price of 14,900 KRW, and its all-time low was 2,840 KRW and was reached on Dec 10, 2024. View more price dynamics on 261780 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
261780 stock is 3.16% volatile and has beta coefficient of 0.70. Track CHA VACCINE RESEARCH INSTITUTE stock price on the chart and check out the list of the most volatile stocks — is CHA VACCINE RESEARCH INSTITUTE there?
Today CHA VACCINE RESEARCH INSTITUTE has the market capitalization of 86.91 B, it has increased by 3.46% over the last week.
Yes, you can track CHA VACCINE RESEARCH INSTITUTE financials in yearly and quarterly reports right on TradingView.
261780 net income for the last quarter is −1.87 B KRW, while the quarter before that showed −2.71 B KRW of net income which accounts for 30.91% change. Track more CHA VACCINE RESEARCH INSTITUTE financial stats to get the full picture.
No, 261780 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 49.00 employees. See our rating of the largest employees — is CHA VACCINE RESEARCH INSTITUTE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHA VACCINE RESEARCH INSTITUTE EBITDA is −8.12 B KRW, and current EBITDA margin is −2.70 K%. See more stats in CHA VACCINE RESEARCH INSTITUTE financial statements.
Like other stocks, 261780 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHA VACCINE RESEARCH INSTITUTE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHA VACCINE RESEARCH INSTITUTE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHA VACCINE RESEARCH INSTITUTE stock shows the strong sell signal. See more of CHA VACCINE RESEARCH INSTITUTE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.